Evaluating the Risks & Benefits of Immunosuppression in Patients Prior to Gene Therapy Treatment
Time: 9:00 am
day: Day Two
Details:
- Tackling pre-existing immunity by utilizing enzymes to cleave IgGs in the blood that exist for the capsid
- Understanding the optimal time within the treatment phase to dose withb Immunosuppressants
- Exploring the ability to redose patients after immunosuppression treatments
